[{"id":"1f1d6176-deb9-471d-b25a-15537effeb32","acronym":"","url":"https://clinicaltrials.gov/study/NCT04506983","created_at":"2021-01-19T20:11:24.824Z","updated_at":"2024-07-02T16:36:17.199Z","phase":"Phase 1","brief_title":"GPC3-CAR-T Cells for the Hepatocellular Carcinoma","source_id_and_acronym":"NCT04506983","lead_sponsor":"Beijing Tsinghua Chang Gung Hospital","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 positive","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3-CAR-T Cells"],"overall_status":"Suspended","enrollment":" Enrollment 12","initiation":"Initiation: 06/10/2022","start_date":" 06/10/2022","primary_txt":" Primary completion: 06/10/2023","primary_completion_date":" 06/10/2023","study_txt":" Completion: 10/10/2023","study_completion_date":" 10/10/2023","last_update_posted":"2022-02-14"}]